Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PEPI: Protracted Etoposide in a Phase II Upfront Window for Induction Therapy for High Risk Neuroblastoma

NCT00578864 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT00578864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00578864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PEPI: Protracted Etoposide in a Phase II Upfront Window for Induction Therapy for High Risk Neuroblastoma
Lead sponsor
Baylor College of Medicine
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2007
Completion date
March 31, 2015
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma